InsiderClue

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 0/25
Result 36,704 decisions over 12 months
Reset filters
Direction ?
Both36,704 Bought13,311 Sold23,393
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Plan: Discretionary
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
ABOS Acumen Pharmaceuticals, Inc.
21 Jan 2026
OConnell Daniel Joseph
Chief Executive Officer
Sold at will
9,346
$16.93K
1.0%
ACR ACRES Commercial Realty Corp.
21 Jan 2026
Eagle Point Credit Management LLC
10% owner indirect
Sold at will
692
$15.27K
0.1%
CABA Cabaletta Bio, Inc.
21 Jan 2026
Gerard Michael
General Counsel
Bought
6,600
$14.98K
opened
NYC American Strategic Investment Co.
21 Jan 2026
SCHORSCH NICHOLAS S
10% owner indirect
Bought
1,365
$14.70K
0.1%
MXF MEXICO FUND INC
21 Jan 2026
Saba Capital Management, L.P.
10% owner indirect
Bought
550
$11.71K
0.0%
OM Outset Medical, Inc.
21 Jan 2026
Trigg Leslie
Chair and CEO
Sold at will
2,120
$10.71K
2.0%
USIO Usio, Inc.
21 Jan 2026
National Services, Inc
10% owner
Sold at will
7,512
$10.24K
0.3%
CABA Cabaletta Bio, Inc.
21 Jan 2026
Bollard Catherine
Director
Bought
4,405
$9.98K
441%
RNXT RenovoRx, Inc.
21 Jan 2026
Agah Ramtin
Chief Medical Officer
Bought
10,000
$9.98K
1.3%
OM Outset Medical, Inc.
21 Jan 2026
Brottem John L.
General Counsel
Sold at will
1,180
$5.91K
3.2%
OM Outset Medical, Inc.
21 Jan 2026
Nash Marc
EVP Operations R&D & Service
Sold at will
980
$4.88K
2.3%
ABOS Acumen Pharmaceuticals, Inc.
21 Jan 2026
Zuga Matt
CFO & Chief Business Officer
Sold at will
2,473
$4.47K
0.8%
ABOS Acumen Pharmaceuticals, Inc.
21 Jan 2026
Siemers Eric
Chief Medical Officer
Sold at will
2,331
$4.20K
0.9%
ABOS Acumen Pharmaceuticals, Inc.
21 Jan 2026
Barton Russell
Chief Operating Officer
Sold at will
2,315
$4.18K
1.1%
ABOS Acumen Pharmaceuticals, Inc.
21 Jan 2026
Meisner Derek M
Chief Legal Officer & Corp Sec
Sold at will
2,247
$4.06K
1.2%
IRIX IRIDEX CORP
21 Jan 2026
Dizon Romeo R
Chief Financial Officer
Bought 2×
2,159
$3.23K
2.2%
RCG RENN Fund, Inc.
21 Jan 2026
STAHL MURRAY
President/Co-Portfolio Manager indirect
Bought 6×
774
$2.09K
0.2%
LUCY Innovative Eyewear Inc
21 Jan 2026
Gross Harrison R.
Chief Executive Officer
Bought
1,500
$1.98K
12.3%
KPTI Karyopharm Therapeutics Inc.
21 Jan 2026
Abate Kristin
Chief Accounting Officer
Sold at will
265
$1.58K
1.2%
CDNS Cadence Design Systems
21 Jan 2026
GAVRIELOV MOSHE
Director
Sold at will
5
$1.56K
0.5%
RCG RENN Fund, Inc.
21 Jan 2026
STAHL MURRAY
President/Co-Portfolio Manager
Bought
360
$972.00
0.3%
NOMA Nomadar Corp.
21 Jan 2026
Sport City Cadiz S.L.
10% owner
Bought
125
$513.75
0.0%
BCDA BioCardia, Inc.
21 Jan 2026
Altman Peter
President and CEO
Bought
300
$402.00
0.1%
TPL Texas Pacific Land Corporation
21 Jan 2026
HORIZON KINETICS ASSET MANAGEMENT LLC
10% owner
Bought
1
$343.48
0.0%
AEO AMERICAN EAGLE OUTFITTERS INC
20 Jan 2026
SCHOTTENSTEIN JAY L
Exec Chairman & CEO indirect
Sold at will
500,000
$12.64M
6.7%
GME GameStop Corp.
20 Jan 2026
Cohen Ryan
President, CEO and Chairman
Bought
500,000
$10.56M
1.3%
UA Under Armour, Inc.
20 Jan 2026
WATSA V PREM ET AL
10% owner indirect
Bought
1,769,581
$9.94M
15.7%
MS Morgan Stanley
20 Jan 2026
SAPERSTEIN ANDREW M
Co-President
Sold at will 6×
30,330
$5.57M
9.8%
MS Morgan Stanley
20 Jan 2026
GROSSMAN ERIC F
Chief Legal/Admin Officer
Sold at will
21,555
$3.97M
11.2%
AVO Mission Produce, Inc.
20 Jan 2026
Globalharvest Holdings Venture Ltd
10% owner
Bought
300,000
$3.75M
3.3%
MS Morgan Stanley
20 Jan 2026
Pizzi Michael A.
Head Technology & Operations
Sold at will
20,000
$3.69M
13.5%
MS Morgan Stanley
20 Jan 2026
YESHAYA SHARON
Chief Financial Officer
Sold at will
15,838
$2.94M
10.5%
PTGX Protagonist Therapeutics, Inc
20 Jan 2026
PATEL DINESH V PH D
President and CEO
Sold at will
34,438
$2.84M
5.6%
GRND Grindr Inc.
20 Jan 2026
Lu James Fu Bin
10% owner indirect
Sold at will
200,000
$2.41M
0.9%
ECAT BlackRock ESG Capital Allocation Term Trust
20 Jan 2026
Saba Capital Management, L.P.
10% owner indirect
Sold at will
102,837
$1.58M
0.4%
MS Morgan Stanley
20 Jan 2026
SMITH CHARLES A
Chief Risk Officer
Sold at will
8,500
$1.55M
6.7%
MS Morgan Stanley
20 Jan 2026
CRAWLEY MANDELL
Chief Client Officer
Sold at will 5×
7,860
$1.44M
10.3%
MDGL MADRIGAL PHARMACEUTICALS, INC.
20 Jan 2026
Taub Rebecca
Director
Sold at will
2,238
$1.10M
0.5%
AGX ARGAN INC
20 Jan 2026
Jeffrey John Ronald Jr.
Director
Sold at will
2,700
$1.03M
17.0%
PTGX Protagonist Therapeutics, Inc
20 Jan 2026
MOLINA ARTURO MD
Chief Medical Officer
Sold at will
9,514
$784.71K
8.9%
PTGX Protagonist Therapeutics, Inc
20 Jan 2026
Ali Asif
Chief Financial Officer
Sold at will
8,588
$708.34K
9.9%
MIRM Mirum Pharmaceuticals, Inc.
20 Jan 2026
Quan Joanne
CHIEF MEDICAL OFFICER
Sold at will
6,911
$623.85K
37.9%
ALMU Aeluma, Inc.
20 Jan 2026
Tompkins Mark N.
10% owner
Sold at will 2×
30,000
$620.62K
1.5%
JBHT J.B. Hunt
20 Jan 2026
Hobbs Nicholas
EVP and COO
Sold at will
3,038
$613.58K
3.3%
IRMD IRADIMED CORP
20 Jan 2026
Susi Roger E.
CEO, PRESIDENT, CHAIRMAN indirect
Sold at will 3×
5,000
$509.22K
0.2%
AMPX Amprius Technologies, Inc.
20 Jan 2026
Sun Kang
Director
Sold at will
43,185
$476.27K
3.0%
REPX Riley Exploration Permian, Inc.
20 Jan 2026
Bluescape Riley Exploration Holdings LLC
10% owner
Sold at will
16,548
$458.56K
0.4%
SRZN Surrozen, Inc./DE
20 Jan 2026
Kutzkey Tim
Director indirect
Bought 2×
18,052
$353.82K
1.8%
SRZN Surrozen, Inc./DE
20 Jan 2026
COLUMN GROUP III GP, LP
10% owner indirect
Bought 2×
18,052
$353.82K
1.8%
OLMA Olema Pharmaceuticals, Inc.
20 Jan 2026
Harmon Cyrus
Director
Sold at will
10,000
$268.80K
1.4%
Showing 27,301–27,350 of 36,704. ← Newer Page 547 of 735 Older →